2-methylpentane has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aquilina, JA; Bellotti, V; Cobb, AJ; Gallimore, JR; Gray, GA; Hawkins, PN; Hirschfield, GM; Jenvey, MC; Kahan, MC; Kolstoe, SE; Ley, SV; Myers, RM; Pepys, MB; Polara, A; Robinson, CV; Sabin, CA; Sharif, I; Smith, MD; Tennent, GA; Thompson, D; Wood, SP | 1 |
| Heinecke, JW | 1 |
2 other study(ies) available for 2-methylpentane and Cardiovascular Diseases
| Article | Year |
|---|---|
Targeting C-reactive protein for the treatment of cardiovascular disease.
Topics: Animals; C-Reactive Protein; Cardiovascular Diseases; Complement System Proteins; Drug Design; Hexanes; Humans; Male; Models, Molecular; Molecular Conformation; Myocardial Infarction; Phosphorylcholine; Rats; Rats, Wistar | 2006 |
Chemical knockout of C-reactive protein in cardiovascular disease.
Topics: Animals; C-Reactive Protein; Cardiovascular Diseases; Choline; Hexanes; Humans; Molecular Structure; Molecular Weight; Phosphorylcholine; Rats | 2006 |